# Waterstone

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/waterstone

- Industry: Pharmaceuticals
- Headquarters: Wuhan, China
- Website: www.waterstonechina.com
- Total disclosed funding: $76M
- Latest round: Series C (Nov 30, 2020)
- Investors on record: 9

## About

Established in 2009 and based in Wuhan, China. Waterstone is a biotechnology medicine company that focuses on the research and development of molecular medicine and new drugs. It has more than 30 invention patents that have been authorized by China, the United States and Japan. Faming Zhang, the founder and chairman of the company, graduated from Wuhan University, used to work at the Institute of Biophysics, Chinese Academy of Sciences, and is a professor at the School of Pharmacy, Wuhan University. Waterstone cooperated with Harvard University, PKU HEALTHCARE, VIFOR PHARMA, and other universities and institutions. The company has 3 branch offices in Shanghai and Tianmen. In November 2020, Waterstone raised a series C+ funding for CNY 100 million.

Waterstone's main business is the research, development, production, and sales of pharmaceutical intermediates, APIs, and preparations for major diseases such as cancer, NASH, diabetes, and kidney disease. Products include Alogliptin Benzoate, Canagliflozin, and Febuxostat. It has built 4 production lines for polymer drugs from intermediates, and APIs to formulations.

## Funding rounds

- Series C, Nov 30, 2020, $15M — China Merchants Zhiyuan Capital Investment, Wego Capital
- Series C, Aug 14, 2020, $60M — InnoBio Ventures, Shanghai Panxi Capital Management, Yichang State-Owned Investment Group, Guotou Juli Investment Management, Huide Ronghe Industrial Capital
- Angel, Jan 1, 2017 — Lapam Capital, Beijing Yingnuo Dahe Venture Investment, Guotou Juli Investment Management

## Investors

- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Angel
- Beijing Yingnuo Dahe Venture Investment — Angel
- Guotou Juli Investment Management (https://capitalatlas.ai/funds/guotou-juli-investment-management) — Angel, Series C
- InnoBio Ventures — Series C
- Shanghai Panxi Capital Management — Series C
- Yichang State-Owned Investment Group — Series C
- Huide Ronghe Industrial Capital (https://capitalatlas.ai/funds/huide-ronghe-industrial-capital) — Series C
- China Merchants Zhiyuan Capital Investment — Series C
- Wego Capital (https://capitalatlas.ai/funds/wego-capital) — Series C